Account
Cart

No products in the cart.

Awaiting product image

TRELEGY ELLIPTA® 92/55/22

142.00 $

1 in stock

You need to add your prescription
SKU: 86554 Category:

Description

AsthmaTrelegy Ellipta 92/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older.Trelegy Ellipta 92/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of Use:Trelegy Ellipta 92/55/22 mcg is NOT indicated for the relief of acute asthma.COPD (Chronic Obstructive Pulmonary Disease)Trelegy Ellipta 92/55/22 mcg is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist or a combination of a long-acting β2-agonist and a long-acting muscarinic antagonist.

Additional information

Active Pharmacologic ingridient

vilanterol as trifenatate 22 mcg/inh , umeclidinium as bromide 55 mcg/inh , fluticasone furoate 92 mcg/inh
License holder

GLAXO SMITH KLINE (ISRAEL) LTD
Needs cooling?

No
need prescription?

yes
Administration

INHALATION
Dosage Form

POWDER FOR INHALATION
Drug includes

30 Dose inhaler
Patient Insert

https://mohpublic.z6.web.core.windows.net/IsraelDrugs/Rishum01_12_575532623.pdf
Storage Information

Store at room temprature. After opening the aluminium case, the inhaler can be used for up to 6 weeks.

Reviews

There are no reviews yet.

Be the first to review “TRELEGY ELLIPTA® 92/55/22”

Your email address will not be published. Required fields are marked *

Related products

Symbicort Turbuhaler® 80/4.5
0
from
119.00 $
INCRUSE ELLIPTA®
0
from
75.00 $
(Breo Ellipta™)RELVAR ELLIPTA™ 184/22
0
from
137.00 $
(Breo Ellipta™)RELVAR ELLIPTA™ 92/22
0
from
119.00 $
To top
By using this service, I authorize Athenascripts.com or its agents to receive my prescription, supply medications from a pharmacy, and send them to me. I agree to waive my right to a pharmacist consultation (except for medications requiring pharmacological guidance) and understand that I can consult a pharmacist via email or phone.

Additionally, I consent to receive marketing messages from Athenascripts.com at the phone number provided. I understand I will receive notification messages, data rates may apply, and I can reply STOP to opt out.